These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 27209678)

  • 41. Comparison of fatal poisonings by prescription opioids.
    Häkkinen M; Launiainen T; Vuori E; Ojanperä I
    Forensic Sci Int; 2012 Oct; 222(1-3):327-31. PubMed ID: 22884575
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Acetyl-L-carnitine in the management of pain during methadone withdrawal syndrome.
    Janiri L; Martinotti G; Tonioni F; Ghelardini C; Nicolai R; Galeotti N; Mosconi L; Calvani M; Bartolini A; Iannoni E
    Clin Neuropharmacol; 2009; 32(1):35-40. PubMed ID: 18978503
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Simplified methadone conversion.
    Plonk WM
    J Palliat Med; 2005 Jun; 8(3):478-9. PubMed ID: 16021683
    [No Abstract]   [Full Text] [Related]  

  • 44. [Evaluation of methadone dispensing in Belgium--study synopsis].
    Ledoux Y
    J Pharm Belg; 2004; 59(3):69-79. PubMed ID: 15553322
    [No Abstract]   [Full Text] [Related]  

  • 45. Opioid-sparing effect of diclofenac in cancer pain.
    Mercadante S; Sapio M; Caligara M; Serretta R; Dardanoni G; Barresi L
    J Pain Symptom Manage; 1997 Jul; 14(1):15-20. PubMed ID: 9223838
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Methadone: starting dosing information No. 86.
    von Gunten CF
    J Palliat Med; 2004 Apr; 7(2):304-5. PubMed ID: 15130210
    [No Abstract]   [Full Text] [Related]  

  • 47. Methadone as an analgesic: a review of the risks and benefits.
    Terpening CM; Johnson WM
    W V Med J; 2007; 103(1):14-8. PubMed ID: 17432310
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effectiveness of methadone maintenance for heroin addiction.
    Murray JB
    Psychol Rep; 1998 Aug; 83(1):295-302. PubMed ID: 9775685
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Commentary: reaching women drug users with methadone treatment and other HIV prevention services in Tehran.
    Claeson M
    J Public Health Policy; 2011 May; 32(2):231-3. PubMed ID: 21368851
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Methadone rotation for cancer patients with refractory pain in a palliative care unit: an observational study.
    Rhondali W; Tremellat F; Ledoux M; Ciais JF; Bruera E; Filbet M
    J Palliat Med; 2013 Nov; 16(11):1382-7. PubMed ID: 24116946
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Attributing fatal cardiac effects to methadone: what's the evidence?
    Newman RG
    J Addict Dis; 2008; 27(4):1-4. PubMed ID: 19042585
    [No Abstract]   [Full Text] [Related]  

  • 52. Hemodynamic effects of methadone and dihydrocodeine in overdose.
    Afshari R; Maxwell SR; Bateman DN
    Clin Toxicol (Phila); 2007; 45(7):763-72. PubMed ID: 17852162
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Methadone and morphine during anesthesia induction for cardiac surgery. Repercussion in postoperative analgesia and prevalence of nausea and vomiting.
    Udelsmann A; Maciel FG; Servian DC; Reis E; de Azevedo TM; Melo Mde S
    Rev Bras Anestesiol; 2011; 61(6):695-701. PubMed ID: 22063370
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The QTc effect of low-dose methadone for chronic pain: a prospective pilot study.
    Grodofsky S; Edson E; Huang S; Speck RM; Hatchimonji J; Lacy K; Farrar JT; Ashburn MA
    Pain Med; 2015 Jun; 16(6):1112-21. PubMed ID: 25644980
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Withdrawal symptoms during chronic transdermal fentanyl administration managed with oral methadone.
    Ripamonti C; Campa T; De Conno F
    J Pain Symptom Manage; 2004 Mar; 27(3):191-4. PubMed ID: 15010096
    [No Abstract]   [Full Text] [Related]  

  • 56. [Methadone].
    Madsen TB
    Ugeskr Laeger; 1994 Feb; 156(8):1154-5. PubMed ID: 8116098
    [No Abstract]   [Full Text] [Related]  

  • 57. An analysis of the root causes for opioid-related overdose deaths in the United States.
    Webster LR; Cochella S; Dasgupta N; Fakata KL; Fine PG; Fishman SM; Grey T; Johnson EM; Lee LK; Passik SD; Peppin J; Porucznik CA; Ray A; Schnoll SH; Stieg RL; Wakeland W
    Pain Med; 2011 Jun; 12 Suppl 2():S26-35. PubMed ID: 21668754
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Subcutaneous methadone--an issue revisited.
    Hum A; Fainsinger RL; Bielech M
    J Pain Symptom Manage; 2007 Dec; 34(6):573-5. PubMed ID: 17959347
    [No Abstract]   [Full Text] [Related]  

  • 59. Intravenous methadone causes acute toxic and delayed inflammatory encephalopathy with persistent neurocognitive impairments.
    Repple J; Haessner S; Johnen A; Landmeyer NC; Schulte-Mecklenbeck A; Pawlitzki M; Wiendl H; Meyer Zu Hörste G
    BMC Neurol; 2021 Feb; 21(1):85. PubMed ID: 33618681
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acute coronary syndrome after methadone overdose in an opiate-naive patient.
    De Cuyper A; Lambert M; Hantson P
    Acta Clin Belg; 2013; 68(3):250-1. PubMed ID: 24156235
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.